PT Sarana Meditama Metropolitan Tbk
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-89.9% vs price
Base Case (Median)
-82.8% vs price
Bull Case (75th pct.)
-74.3% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $1.09 | -99.7% | High (40%) |
| PE Comparable | $25.49 | -92.3% | Medium (25%) |
| Growth Trajectory DCF | $56.99 | -82.8% | Medium (20%) |
| Graham Number | $75.71 | -77.2% | Medium (40%) |
| EV/EBITDA | $212.92 | -35.9% | Medium (20%) |
| EV/FCF | $95.25 | -71.3% | Medium (20%) |
| Earnings Power Value | $41.60 | -87.5% | Medium (50%) |
Based on 7 out of 8 methods, SAME.JK appears overvalued at the current price of $332.00. The base case fair value of $56.99 implies 82.8% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.